Matches 1 - 41 out of 41


Match Document Document Title
US20110195425 SYSTEMS AND METHODS FOR DIAGNOSING PARASITE INFECTIONS  
Systems and methods for diagnosing parasite infections. According to at least one embodiment of a stabilizing system of the present disclosure, a stabilizing system comprises a stabilizing agent...
US20090298195 SYNTHETIC IMMUNOGLOBULIN DOMAINS WITH BINDING PROPERTIES ENGINEERED IN REGIONS OF THE MOLECULE DIFFERENT FROM THE COMPLEMENTARITY DETERMINING REGIONS  
Method for engineering an immunoglobulin comprising at least one modification in a structural loop region of said immunoglobulin and determining the binding of said immunoglobulin to an epitope of...
US20050118655 Use of parasitic biological agents for diseases prevention and control  
The invention relates to a method of screening a heminthic parasite preparation that affects a regulatory T cell function and a method of treating a disease by altering a regulatory T cell...
US20060127886 Sample-efficient lateral flow immunoassay  
There is provided a lateral flow assay device for detecting the presence or quantity of an analyte residing in a test sample where the lateral flow assay device has a porous membrane in...
US20120114688 VACCINES COMPRISING NON-SPECIFIC NUCLEOSIDE HYDROLASE AND STEROL 24-C-METHYLTRANSFERASE (SMT) POLYPEPTIDES FOR THE TREATMENT AND DIAGNOSIS OF LEISHMANIASIS  
Compositions and methods for preventing, treating and detecting leishmaniasis are disclosed. The compositions generally comprise fusion polypeptides comprising Leishmania antigens, in particular,...
US20060240415 Screening compound libraries using an optical fiber array device capable of simultaneously performing multiple functional assays  
Disclosed is a method of screening Compounds wherein target cells are coated onto a population of microbeads, and wherein each microbead is coated with several cells of the same cellular type and...
US20100035234 VACCINE ASSAYS  
The present invention is directed to methods, assays and compositions for implementing such methods and assays for assessing efficacy of individual components in multi-component vaccines and for...
US20060063185 Methods for detection of pathogens in red blood cells  
The present invention relates to methods for diagnosing a parasitic microorganism that resides in red blood cells, such as Babesia microti.
US20070134740 Compositions and articles for detection of analytes exceeding a pre-set threshold  
The present invention provides a bodily fluid-testing composition for the determination and quantification of a specific ion concentration exceeding a pre-set threshold in a tested fluid, in which...
US20060240491 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection  
The present invention provides hybridomas and antibodies which specifically react with native P. falciparum at a surface of ring stage infected erythrocytes and uses thereof.
US20080107660 Binding Agents  
The invention relates to binding agents which can be induced to aggregate in response to a specific stimulus. In preferred embodiments the binding agents comprise at least a binding member for a...
US20070054262 Methods of identifying optimal variants of peptide epitopes  
The present invention is directed to methods for selecting a variant of a peptide epitope which induces a CTL response against another variant(s) of the peptide epitope, by determining whether the...
US20110081666 ANTI-PSGL-1 INHIBITORS AND SCREENING METHODS  
The present invention is directed to antibodies and binding fragments thereof, which bind with high affinity and specificity to human P-selectin glycoprotein ligand 1 (PSGL-1) and which block both...
US20070141076 Antigen fragments for the diagnosis of Toxoplasma gondii  
The invention described herein relates to a method for identifying antigen fragments of Toxoplasma gondii proteins, and their use as diagnostic and immunogenic agents. Said method is implemented...
US20090215087 Toxoplasma gondii Oocyst Protein  
Recombinant proteins have been developed for the detection of Toxoplasma gondii oocyst proteins for example in biological fluids. Isolated DNA sequences which encode these proteins have also been...
US20160370356 PAPER-BASED IMMUNOASSAY WITH POLYMERIZATION-BASED SIGNAL AMPLIFICATION  
Disclosed herein are paper-based immunoassays useful for the detection of analytes, kits for the same and methods of using the same.
US20060211056 Leishmania antigens suitable for a diagnostic kit of Leishmania  
A purified Leishmania infantum polypeptide comprising at least 10 consecutive amino acids of a protein is provided. The protein is mitochondrial integral ADP/ATP carrier protein, NADH-cytochrome...
US20110039256 DETECTION METHOD  
A method for detecting the presence of a diagnostic moiety indicative of exposure to an infectious organism in a biological sample taken from a human or animal, said method comprising; (a) adding...
US20060002950 Immunomodulatory protein derived from Trypanosomes and uses thereof  
The present invention relates to the field of immunomodulation. More particularly, the present invention relates to the identification and isolation of a polypeptide derived from Trypanosomes that...
US20100120017 RAPID IMMUNE CHROMATOGRAPHIC DETECTION BY AMPLIFICATION OF THE COLLOIDAL GOLD SIGNAL  
The present invention relates to a rapid immunochromatographic test device suitable to detect more than one target in a single assay at the same time, uses of said device for detecting diseases in...
US20050260692 Positive selection in the immuno-dominant surface antigen 1 (SAG1) of sarcocystis neurona, agent of EPM: potential as a diagnostic reagent and as a component of a sub-unit vaccine  
Vaccines against surface antigen gene 1 (SAG1) of Sarcocystis neurona are described, including polypeptide and DNA vaccines. Methods of diagnosis and diagnostic test kits for subtypes of SAG1 are...
US20050198695 Nematode ATP synthase subunit E-like sequences  
Nucleic acid molecules from nematodes encoding ATP synthase subunit E polypeptides are described. ATP synthase subunit E-like polypeptide sequences are also provided, as are vectors, host cells,...
US20080248498 METHODS AND COMPOSITIONS TO DIAGNOSE TRICHOMONAS INFECTION  
The present invention provides methods and compositions for diagnosing Trichomonas infection by detecting an antibody that specifically binds a Trichomonas α-actinin protein in a sample from a...
US20140349873 Methods of Producing Competitive Aptamer FRET Reagents and Assays  
Methods are described for the production and use of fluorescence resonance energy transfer (FRET)-based competitive displacement aptamer assay formats. The assay schemes involve FRET in which the...
US20090196884 Malaria Vaccines  
The present invention relates to a synthetic antigenic sequence which represents a combination of epitope-containing sequences from the highly polymorphic block 2 repeat region of K1-type...
US20100279319 Detection of plasmodium falciparum histidine-rich protein II in saliva malaria patients  
The detection of PfHRP II in saliva offers a practical, cost-effective alternative to PfHRP II detection in blood as a means for diagnosis of malaria. Collection of saliva is non-invasive, simple,...
US20070172502 Compositions and methods for treatment of Toxoplasma gondii and other apicomplexans  
Pyrimidine auxotroph mutants of apicomplexans are provided which are mutated in one of six enzymes of the de novo pyrimidine biosynthesis pathway. Also provided are methods of protecting an animal...
US20060178292 Methods and compositions of ecdysozoan molt inhibition  
In general, this invention relates to nucleic acid and amino acid sequences involved in molting and the use of these sequences as targets for the development of compounds that disrupt Ecdysozoan...
US20110098326 2-FLUOROTHIAZOLE DERIVATIVES USEFUL AS IMAGING AGENTS; METHODS OF SYNTHESIS, AND METHODS OF USE  
Novel 18F-labeled thiazole derivatives useful for imaging of metabotropic glutamate subtype 5 receptors (mGluR5) in living mammalian brain are disclosed herein. Also disclosed herein is a...
US20060199175 Novel field testing method and device for detection of equine protozoal myeloencephalitis  
The present invention discloses a quick, simple, qualitative and semi-quantitative immunologic method and device in a field test kit format for the detection and the stage of infection of certain...
US20070161057 Methods, compositions, and kits for detecting cyrptosporidium pathogens  
The invention provides an efficient, sensitive, and reliable method for detection of parasites such as Cryptosporidium by efficiently extracting molecular markers or antigens using non-ionic...
US20050287609 Methods and compositions for detection of equine tapeworm infections  
Methods for detection of a tapeworm in an animal are provided, comprising contacting a biological sample from the animal with at least one antibody capable of binding to an antigen derived from...
US20060234317 Method of screening  
A method of detecting the presence of a functionally inhibitory immunointeractive molecule in a biological sample. Preferably, the immunointeractive molecule is directed to a pathogen derived...
US20050164168 Method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines  
The inventive subject matter relates to a competitive method for the diagnosis of latent infectious disease, such as Mycobacterium tuberculosis, by estimating, the concentration of cytokine, such...
US20060051780 Polymorphic Plasminogen genes and uses thereof  
The present invention relates to polymorphic Plasminogen genes and polypeptides. In particular, the present invention provides assays for the detection of Plasminogen polymorphisms and mutations...
US20120202191 DETECTION METHOD BASED ON TIME RESOLVED REAL TIME FLUORESCENT ENERGY TRANSFER (TR-FRET)  
A method for detecting the presence of a diagnostic moiety indicative of exposure to an infectious organism in a biological sample taken from a human or animal, said method comprising use of a...
US20070015224 Methods and compositions to diagnose Trichomonas infection  
The present invention provides methods and compositions for diagnosing Trichomonas infection by detecting an antibody that specifically binds a Trichomonas α-actinin protein in a sample from a...
US20070003987 Screening method for substance binding to merozoite surface protein-1/42  
Disclosed is a method of screening a test substance for possession of binding activity for possession of binding activity for MSP42 or a fragment thereof, the method comprising the steps of:...
US20090215086 Biomarkers for Babesia  
The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying babesia status in a patient. In particular, the biomarkers of this invention are...
US20060073524 Definitive diagnosis of EPM in the horse  
The present invention concerns detection of acute, chronic, or sub-acute equine protozoal myeloencephalitis by detecting antibodies in serum or CSF or the lymphoblastogenesis response to a...
US20070184497 Clinical diagnostic reagent and diagnostic method for testing infection of adult taenia solium and taenia saginata  
Present invention provides a diagnostic means for testing infection of adult in humans parasitized with adult Taenia solium and Taenia saginata. It was found that a hydrophobic ligand binding...

Matches 1 - 41 out of 41